Select and download resources for LEQVIO®
Select all resources below
For US Health Care Professionals Only
Select all resources below
Have questions?
We're happy to assist you
833-LEQVIO2
(833-537-8462)
Monday to Friday, 8 am to 8 pm ET
Find your
dedicated
specialist
Chat with us
Monday to Friday,
8 am to 8 pm ET
IMPORTANT SAFETY INFORMATION
LEQVIO is contraindicated in patients with a prior serious hypersensitivity reaction to inclisiran or any of the excipients in LEQVIO. Serious hypersensitivity reactions have included angioedema. Adverse reactions in clinical trials (≥3% of patients treated with LEQVIO and more frequently than placebo) were injection site reaction, arthralgia, and bronchitis.
Please click here for LEQVIO full Prescribing Information.
INDICATION
LEQVIO (inclisiran) injection is indicated as an adjunct to diet and statin therapy for the treatment of adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH), to reduce low-density lipoprotein cholesterol (LDL-C).
Please click here for LEQVIO full Prescribing Information.